Agnes Gardner
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Bone health and treatments
Papers in
-
- Cell death mechanisms and regulation 3
- Protein Kinase Regulation and GTPase Signaling 2
- Oncology 6
- CAR-T cell therapy research 3
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Alan Lichtenstein (10 shared papers)Yiping Tu (6 shared papers)Fenghao Xu (4 shared papers)Catherine Fady (6 shared papers)F Jacoby (1 shared paper)Dianne C. Duffey (1 shared paper)Ana M. Aparicio (1 shared paper)James R. Berenson (1 shared paper)
- Journals
- Molecular Therapy (2 papers)Stem Cells Translational Medicine (2 papers)Cancer Immunology Immunotherapy (2 papers)British Journal of Haematology (1 paper)Journal of Interferon & Cytokine Research (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Agnes Gardner
14 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 98
- Hematology 303
- Oncology 406
- Virology 65
- Molecular Biology 685
- Business and International Management 14
Countries citing papers authored by Agnes Gardner
This map shows the geographic impact of Agnes Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnes Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnes Gardner more than expected).
Fields of papers citing papers by Agnes Gardner
This network shows the impact of papers produced by Agnes Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnes Gardner. The network helps show where Agnes Gardner may publish in the future.
Co-authors
The 25 scholars most cited alongside Agnes Gardner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 310 | |
| 2 | 1998 | 211 | |
| 3 | The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. | 2000 | 193 |
| 4 | 2013 | 146 | |
| 5 | 1998 | 89 | |
| 6 | 1997 | 86 | |
| 7 | 1995 | 45 | |
| 8 | 2014 | 20 | |
| 9 | 1997 | 17 | |
| 10 | 1993 | 10 | |
| 11 | 1992 | 10 | |
| 12 | 2012 | 5 | |
| 13 | 1993 | 3 | |
| 14 | 2014 | 3 |
About Agnes Gardner
Agnes Gardner is a scholar working on Molecular Biology, Oncology, Immunology, Hematology and Virology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Cell death mechanisms and regulation (3 papers), T-cell and B-cell Immunology (3 papers), Multiple Myeloma Research and Treatments (3 papers), Immune Cell Function and Interaction (3 papers), HIV Research and Treatment (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Hematology (303 citations), Oncology (406 citations), Virology (65 citations), Molecular Biology (685 citations) and Business and International Management (14 citations). Agnes Gardner has collaborated with scholars based in United States and Australia. Frequent co-authors include Alan Lichtenstein, Yiping Tu, Fenghao Xu, Catherine Fady, F Jacoby, Dianne C. Duffey, Ana M. Aparicio, James R. Berenson, Patrick Michl and Diane Prager. Their work appears in journals such as Molecular Therapy, Stem Cells Translational Medicine, Cancer Immunology Immunotherapy, British Journal of Haematology and Journal of Interferon & Cytokine Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.